Evidence map›Paper›PMID 30811871›Full record

ArticleMolecular genetics & genomic medicine2019

The protective impact of betaine on the tissue structure and renal function in isoproterenol-induced myocardial infarction in rat.

Mohammad Maram Ghartavol, Shiva Gholizadeh-Ghaleh Aziz, Ghader Babaei, Gholam Hossein Farjah, Mohammad Hassan Khadem Ansari

Open access · goldAbstract read
In one paragraph

Article in Molecular genetics & genomic medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Betaine Alters the Interplay of the Adenosine andInternational journal of molecular sciences · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Implication of MAPK, Lipocalin-2, and Fas in the protective action of liposomal resveratrol against isoproterenol-induced kidney injury.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mohammad Maram GhartavolDepartment of Clinical Biochemistry, Urmia University of Medical Sciences, Urmia, Iran.
Shiva Gholizadeh-Ghaleh AzizDepartment of Clinical Biochemistry, Urmia University of Medical Sciences, Urmia, Iran.ORCID 0000-0003-1949-4381
Ghader BabaeiDepartment of Clinical Biochemistry, Urmia University of Medical Sciences, Urmia, Iran.
Gholam Hossein FarjahDepartment of Anatomy, Urmia University of Medical Sciences, Urmia, Iran.
Mohammad Hassan Khadem AnsariDepartment of Clinical Biochemistry, Urmia University of Medical Sciences, Urmia, Iran.ORCID 0000-0002-5145-9378
Urmia University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMyocardial infarction is one of the most common life threatening diseases that may lead to renal disorders via oxidative stress and inflammation. Betaine is a safe and well-tolerated compound exhibiting beneficial antioxidant and anti-inflammatory properties. Previous studies have demonstrated protective effects of betaine against myocardial infarction and renal injury. This study aimed to investigate the protective effect of betaine on tissue structure and renal function after isoprenaline-induced myocardial infarction in rats.

methodsFifty Wistar strain male albino rats, weighing 200 ± 10, were selected for the study. The animals were housed individually under standard environmental conditions (Light-dark cycle, temperature and constant humidity) for 1 week. After acclimatization, they were randomly divided into five groups. G1, G2, and G3 groups received betaine at doses of 50, 150, and 250 mg/kg body weight/day via gavage for a period of 60 days. After 60 days, isoprenaline is injected subcutaneously (200 mg/kg body weight). In the isoprenaline group (G4), the rats were injected with isoprenaline (200 mg/kg body weight) and the control group (G5) received a standard diet (Without isoprenaline). Then, isoproterenol solution was used for induction of myocardial infarction. At the end, the expression of nitric oxide synthase (iNOS) protein was detected using immunohistochemical analysis and kidney tissues were assessed via histopathological analysis. In addition, serum level of TNF-α and creatinine level were measured via ELISA test and colorimetric methods, respectively.

resultsThe results of our study indicate that isoproterenol-induced renal histopathological injury without changing creatinine level. Betaine has protective effects against renal injuries induced by isoprenaline and the expression of nitric oxide synthase (nNOS) protein showed no significant difference in all groups. Further, betaine reduced TNF-α level significantly.

conclusionAccording to our results, betaine has protective effects on isoprenaline-induced renal failure via a decrease in TNF-α level and nitric oxide synthase.

Indexed as

AnimalsBetaineCardiotonic AgentsIsoproterenolKidneyMaleMyocardial InfarctionMyocytes, CardiacNitric Oxide Synthase Type IIRatsRats, WistarRenal InsufficiencyTumor Necrosis Factor-alphaBetaineCardiotonic AgentsIsoproterenolNitric Oxide Synthase Type IITumor Necrosis Factor-alphabetainecreatinineisoprenalinekidneymyocardial infarctionNOSTNF-α

Identifiers

PMID30811871
PMCPMC6465653
OpenAlexW2918555220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.